Journal of Mass Spectrometry, Journal Year: 2024, Volume and Issue: 59(12)
Published: Nov. 15, 2024
ABSTRACT Type 2 diabetes mellitus is a global health problem, placing patients at higher risk of developing cardiovascular diseases and cancer. This study investigates the antidiabetic potential Cassia bakeriana bark extracts fractions. We evaluate their ability to inhibit α‐amylase α‐glucosidase enzymes advanced glycation end‐products (AGEs). The antioxidant was also examined. Extracts were prepared through maceration with hexane (HE) ethanol (EE), fractions obtained via liquid–liquid extraction from EE. Anti‐enzymatic, anti‐glycation, antioxidant, cytotoxic assays conducted in 96‐well plates using different concentrations samples determine half‐maximal inhibitory concentration (IC 50 ). Active further analyzed HPLC‐(−)‐ESI‐MS/MS. ethyl acetate fraction (EAF) demonstrated high percentage inhibition (94.0%) promising IC value 1.05 μg mL −1 . Additionally, EAF displayed 61.5% α‐glucosidase, an 537 EE, EAF, n ‐butanol (BF) exhibited strong anti‐glycation capacities. Furthermore, BF, dichloromethane showed activity DPPH ORAC methodologies. Cytotoxic evaluated Vero cells, revealing no adverse effects on cell viability (CC > 512.0 predominantly comprised proanthocyanidins, flavonoids, anthraquinone, representing main constituents C. bark. provides first assessment comprehensive analysis chemical composition its active fractions, offering hope for future treatments.
Language: Английский